Global Leader, Cancer Vaccine Development

GlaxoSmithKline; Philadelphia (Philadelphia County); On-site; USD 341,000 - 568,000; Full time

Job summary

GlaxoSmithKline is seeking a senior leader to drive global development of a cancer vaccine asset from early development through approval and launch across major markets. You will build and lead a cross-functional MDT, align stakeholders, and shape the development strategy for differentiated vaccine medicines.

The role requires extensive oncology drug development experience, strategic leadership, and a track record of regulatory submissions, with a focus on delivering value to patients and

Qualifications

• Advanced degree including MD, PhD, PharmD, MBA, MS.
• Oncology drug development expertise in the global pharmaceutical/biotechnology industry.
• Experience leading successful development and registration of medicines; experience with cancer vaccines, therapeutic vaccines, or immuno-oncology combination products.
• Filing experience with BLA/NDA/MAA submissions as a core responsibility.

Responsibilities

• Act as single point of accountability for global cancer vaccine development from C2P2 through approval and launch.
• Lead the multi-disciplinary MDT spanning clinical development, immunology, manufacturing, regulatory, safety, medical affairs and commercial.
• Establish a compelling vision for the cancer vaccine within GSK's Oncology R&D strategy and translate it into asset plans.
• Deliver evidence packages to support regulatory approval, market access and lifecycle management.
• Prioritize asset portfolio options and drive go/no-go decisions with clear inflection points.
• Ensure quality and compliance oversight in line with R&D expectations.

Skills

Oncology drug development

Global regulatory submissions

Leadership in matrix organizations

Strategic planning in immuno-oncology

Stakeholder management

Education

Advanced degree including MD, PhD, PharmD, MBA, MS

Job description

GlaxoSmithKline is seeking a senior leader to drive global development of a cancer vaccine asset from early development through approval and launch across major markets. You will build and lead a cross-functional MDT, align stakeholders, and shape the development strategy for differentiated vaccine medicines.

The role requires extensive oncology drug development experience, strategic leadership, and a track record of regulatory submissions, with a focus on delivering value to patients and